These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24639549)

  • 21. Inhibition of Dipeptidyl Peptidase-4 Impairs Ventricular Function and Promotes Cardiac Fibrosis in High Fat-Fed Diabetic Mice.
    Mulvihill EE; Varin EM; Ussher JR; Campbell JE; Bang KW; Abdullah T; Baggio LL; Drucker DJ
    Diabetes; 2016 Mar; 65(3):742-54. PubMed ID: 26672095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dipeptidyl peptidase 4 inhibitors and their potential immune modulatory functions.
    Shao S; Xu Q; Yu X; Pan R; Chen Y
    Pharmacol Ther; 2020 May; 209():107503. PubMed ID: 32061923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered dipeptidyl peptidase-4 activity during the progression of hyperinsulinemic obesity and islet atrophy in spontaneously late-stage type 2 diabetic rats.
    Kirino Y; Sato Y; Kamimoto T; Kawazoe K; Minakuchi K
    Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E372-9. PubMed ID: 21139073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DPP4 deletion in adipose tissue improves hepatic insulin sensitivity in diet-induced obesity.
    Romacho T; Sell H; Indrakusuma I; Roehrborn D; Castañeda TR; Jelenik T; Markgraf D; Hartwig S; Weiss J; Al-Hasani H; Roden M; Eckel J
    Am J Physiol Endocrinol Metab; 2020 May; 318(5):E590-E599. PubMed ID: 31891536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
    Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
    Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dapagliflozin promotes beta cell regeneration by inducing pancreatic endocrine cell phenotype conversion in type 2 diabetic mice.
    Wei R; Cui X; Feng J; Gu L; Lang S; Wei T; Yang J; Liu J; Le Y; Wang H; Yang K; Hong T
    Metabolism; 2020 Oct; 111():154324. PubMed ID: 32712220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dipeptidyl peptidase-4 inhibitor anagliptin ameliorates diabetes in mice with haploinsufficiency of glucokinase on a high-fat diet.
    Nakaya K; Kubota N; Takamoto I; Kubota T; Katsuyama H; Sato H; Tokuyama K; Hashimoto S; Goto M; Jomori T; Ueki K; Kadowaki T
    Metabolism; 2013 Jul; 62(7):939-51. PubMed ID: 23790528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic vaccine against IL-1β improved glucose control in a mouse model of type 2 diabetes.
    Zhang Y; Yu XL; Zha J; Mao LZ; Chai JQ; Liu RT
    Life Sci; 2018 Jan; 192():68-74. PubMed ID: 29155303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beneficial effects of vildagliptin combined with miglitol on glucose tolerance and islet morphology in diet-controlled db/db mice.
    Ishibashi K; Hara A; Fujitani Y; Uchida T; Komiya K; Tamaki M; Abe H; Ogihara T; Kanazawa A; Kawamori R; Watada H
    Biochem Biophys Res Commun; 2013 Nov; 440(4):570-5. PubMed ID: 24103756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Degradation of Incretins and Modulation of Blood Glucose Levels by Periodontopathic Bacterial Dipeptidyl Peptidase 4.
    Ohara-Nemoto Y; Nakasato M; Shimoyama Y; Baba TT; Kobayakawa T; Ono T; Yaegashi T; Kimura S; Nemoto TK
    Infect Immun; 2017 Sep; 85(9):. PubMed ID: 28630069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of obesity-induced renal injury in male mice by DPP4 inhibition.
    Nistala R; Habibi J; Lastra G; Manrique C; Aroor AR; Hayden MR; Garro M; Meuth A; Johnson M; Whaley-Connell A; Sowers JR
    Endocrinology; 2014 Jun; 155(6):2266-76. PubMed ID: 24712875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gallic acid attenuates high-fat diet fed-streptozotocin-induced insulin resistance via partial agonism of PPARγ in experimental type 2 diabetic rats and enhances glucose uptake through translocation and activation of GLUT4 in PI3K/p-Akt signaling pathway.
    Gandhi GR; Jothi G; Antony PJ; Balakrishna K; Paulraj MG; Ignacimuthu S; Stalin A; Al-Dhabi NA
    Eur J Pharmacol; 2014 Dec; 745():201-16. PubMed ID: 25445038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue expression of DPP-IV in obesity-diabetes and modulatory effects on peptide regulation of insulin secretion.
    McKillop AM; Stevenson CL; Moran BM; Abdel-Wahab YHA; Flatt PR
    Peptides; 2018 Feb; 100():165-172. PubMed ID: 29412816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased acylcarnitine content improves insulin sensitivity in experimental mice models of insulin resistance.
    Liepinsh E; Makrecka-Kuka M; Makarova E; Volska K; Svalbe B; Sevostjanovs E; Grinberga S; Kuka J; Dambrova M
    Pharmacol Res; 2016 Nov; 113(Pt B):788-795. PubMed ID: 26621248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pancreastatin inhibitor PSTi8 protects the obesity associated skeletal muscle insulin resistance in diet induced streptozotocin-treated diabetic mice.
    Gupta AP; Garg R; Singh P; Goand UK; Syed AA; Valicherla GR; Riyazuddin M; Mugale MN; Gayen JR
    Eur J Pharmacol; 2020 Aug; 881():173204. PubMed ID: 32439261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ZY15557, a novel, long acting inhibitor of dipeptidyl peptidase-4, for the treatment of Type 2 diabetes mellitus.
    Jain MR; Joharapurkar AA; Kshirsagar SG; Patel VJ; Bahekar RH; Patel HV; Jadav PA; Patel PR; Desai RC
    Br J Pharmacol; 2017 Jul; 174(14):2346-2357. PubMed ID: 28452143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased plasma DPP4 activity is predictive of prediabetes and type 2 diabetes onset in Chinese over a four-year period: result from the China National Diabetes and Metabolic Disorders Study.
    Zheng T; Gao Y; Baskota A; Chen T; Ran X; Tian H
    J Clin Endocrinol Metab; 2014 Nov; 99(11):E2330-4. PubMed ID: 25029421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GABA dramatically improves glucose tolerance in streptozotocin-induced diabetic rats fed with high-fat diet.
    Sohrabipour S; Sharifi MR; Talebi A; Sharifi M; Soltani N
    Eur J Pharmacol; 2018 May; 826():75-84. PubMed ID: 29391158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic Glucose Metabolism Disorder Induced by Adipose Tissue-Derived miR-548ag via DPP4 Upregulation.
    Chu X; Hou Y; Zhang X; Li M; Ma D; Tang Y; Yuan C; Sun C; Liang M; Liu J; Wei Q; Chang Y; Wang C; Zhang J
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of magnesium sulfate administration to improve insulin resistance in type 2 diabetes animal model: using the hyperinsulinemic-euglycemic clamp technique.
    Sohrabipour S; Sharifi MR; Sharifi M; Talebi A; Soltani N
    Fundam Clin Pharmacol; 2018 Dec; 32(6):603-616. PubMed ID: 29869808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.